August 20, 2015
Following a bench trial, a New Jersey federal judge on Thursday validated Merck Sharp & Dohme Corp.'s patent for an anti-nausea drug used during chemotherapy, finding that its claims are not obvious and also determining that a proposed generic drug by Sandoz Inc. would infringe the patent.
February 15, 2013
A New Jersey federal judge on Thursday refused to strike a patent infringement claim from Merck Sharp & Dohme Corp.'s dispute with Sandoz Inc. and Intas Pharmaceuticals Ltd. over its anti-nausea drug Emend, ruling the court has proper jurisdiction over the claim.
June 05, 2012
Merck Sharp & Dohme Corp. is suing Novartis AG unit Sandoz Inc. and India-based Intas Pharmaceuticals Ltd., claiming their plans to make a generic version of Merck's anti-nausea drug Emend would infringe two patents.